ISOWN: accurate somatic mutation identification in the absence of normal tissue controls
Abstract Background A key step in cancer genome analysis is the identification of somatic mutations in the tumor. This is typically done by comparing the genome of the tumor to the reference genome sequence derived from a normal tissue taken from the same donor. However, there are a variety of commo...
Main Authors: | Irina Kalatskaya, Quang M. Trinh, Melanie Spears, John D. McPherson, John M. S. Bartlett, Lincoln Stein |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Genome Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13073-017-0446-9 |
Similar Items
-
Dual Deep Sequencing Improves the Accuracy of Low-Frequency Somatic Mutation Detection in Cancer Gene Panel Testing
by: Hiroki Ura, et al.
Published: (2020-05-01) -
The Roles of Common Variation and Somatic Mutation in Cancer Pharmacogenomics
by: Hiu Ting Chan, et al.
Published: (2019-01-01) -
A method to reduce ancestry related germline false positives in tumor only somatic variant calling
by: Rebecca F. Halperin, et al.
Published: (2017-10-01) -
Understanding and Improving Identification of Somatic Variants
by: Vijayan, Vinaya
Published: (2016) -
Somatic cancer variant curation and harmonization through consensus minimum variant level data
by: Deborah I. Ritter, et al.
Published: (2016-11-01)